Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 20, Pages -Publisher
MDPI
DOI: 10.3390/jcm10204788
Keywords
systemic lupus erythematosus; neuropsychiatric lupus; interleukin-23; interleukin-27; SLEDAI
Categories
Ask authors/readers for more resources
The study aimed to investigate the associations between serum IL-27 and IL-23 levels and disease activity in Polish patients with different manifestations of SLE, but no significant correlations were found. However, patients with NPSLE and LN showed the highest median scores of SLEDAI.
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease characterized by the production of multiple autoantibodies, resulting in tissue and organ damage. Recent studies have revealed that interleukin-23 (IL-23) and interleukin-27 (IL-27) may be therapeutically relevant in selected SLE manifestations. This study aimed to identify associations between serum IL-27 and IL-23 levels and disease activity in Polish patients with different manifestations of SLE: neuropsychiatric lupus (NPSLE), and lupus nephritis (LN). Associations between interleukin levels and oligo-specific antibodies against double-stranded DNA (dsDNA), dose of glucocorticoids, and type of treatment were also analyzed. An enzyme-linked immunosorbent assay was used to assess anti-dsDNA antibodies and analyze the serum concentration of IL-27 and IL-23 from 72 patients aged 19-74 years with confirmed active SLE. Disease activity was measured using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI 2-K). No significant correlations between interleukin levels and SLEDAI score, anti-dsDNA, corticosteroid dose, or type of treatment were noted. Patients with NPSLE and LN presented the highest median scores of SLEDAI.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available